PMC6949673_01
Magnetic resonance imaging (MRI) showing the large renal mass and metastatic lymph nodes. Dramatic reduction in tumor volume in an enlarged lymph node as demonstrated by MRI taken at initial presentation (a) vs. after 5 months of sunitinib (b) and (c). After retroperitoneal lymph node dissection, a complete response was obtained (d).
CRIU2019-2479823.001.jpg
PMC6949673_01_CRIU2019-2479823.001.jpg
fig1
Magnetic resonance imaging (MRI) revealed significant necrotic components in the tumor with no venous tumor thrombus (Figure 1(a)). After four cycles, the para-aortic LN had shrunk by 91% (Figures 1(b) and 1(c)). After LN dissection (Figure 1(d)) the patient achieved a continued response on sunitinib and continued therapy for another 23 months (28 months total).